Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'signaling pathways tyrosine kinase egfr'

Search results for: 'signaling pathways tyrosine kinase egfr'

Items 1-10 of 3593

Page
per page
  1. VEGFR Tyrosine Kinase Inhibitor II
    C4603 VEGFR Tyrosine Kinase Inhibitor II
     1 Citation
    Summary: VEGFR inhibitor
      ≤25 mg/mL
  2. Mutant EGFR inhibitor
    B1103 Mutant EGFR inhibitor
    Summary: Selective Mutated EGFR inhibitor
      Soluble in DMSO
  3. EGFR Inhibitor
    C3327 EGFR Inhibitor
    Summary: EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60.7 mg/mL
  4. DiscoveryProbe™ Tyrosine Kinase Inhibitor Library
    L1028 DiscoveryProbe™ Tyrosine Kinase Inhibitor Library
    Summary: A unique collection of 369 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
  5. Recombinant Rhesus Macaque Fms-related Tyrosine Kinase 3 Ligand
    P1330 Recombinant Rhesus Macaque Fms-related Tyrosine Kinase 3 Ligand
    Summary: Recombinant Rhesus Macaque FLT3L (E.coli, Tag Free, Lyophilized)
  6. CNX-2006
    B3227 CNX-2006
    Summary: mutant-EGFR inhibitor, selective and irreversible
      ≥27.3 mg/mL
  7. Anti-LGR5 & EGFR Antibody (Petosemtamab)
    F1411 Anti-LGR5 & EGFR Antibody (Petosemtamab)
    Summary: Anti-LGR5 & EGFR Antibody (Petosemtamab)
  8. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
     1 Citation
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  9. Phenylalanine & tyrosine metabolism
    M1118 Phenylalanine & tyrosine metabolism
    Summary: A metabolic intermediate that can be synthesized into 3-phenyllactic acid via lactate dehydrogenase.
      ≥30.4 mg/mL
  10. Lazertinib
    BA6330 Lazertinib
    Summary: A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor.

Items 1-10 of 3593

Page
per page